INTEGRA Biosciences Nordic ApS — Credit Rating and Financial Key Figures

CVR number: 43279092
Vallensbækvej 22 A, 2605 Brøndby
kirsten.thuesen@integra-biosciences.com
tel: 20914000

Income statement (kDKK)

2022
2023
2024
Fiscal period length121212
Net sales
Gross profit- 227.212 905.354 115.41
Employee benefit expenses- 772.74-3 631.59-5 408.26
Total depreciation-38.56-48.32
EBIT- 999.95- 764.80-1 341.17
Other financial income4.46148.2091.32
Other financial expenses-37.89- 339.59- 450.01
Pre-tax profit-1 033.38- 956.19-1 699.86
Net earnings-1 033.38- 956.19-1 699.86

Assets (kDKK)

2022
2023
2024
Intangible assets total
Machinery and equipment159.28110.97
Tangible assets total159.28110.97
Investments total
Long term receivables total
Raw materials and consumables1 177.812 623.843 516.95
Inventories total1 177.812 623.843 516.95
Current trade debtors85.303 237.744 536.63
Current amounts owed by group member comp.687.08
Prepayments and accrued income46.0930.9325.90
Current other receivables143.42186.95186.11
Short term receivables total274.803 455.625 435.71
Cash and bank deposits977.972 385.482 470.82
Cash and cash equivalents977.972 385.482 470.82
Balance sheet total (assets)2 430.588 624.2311 534.45

Equity and liabilities (kDKK)

2022
2023
2024
Share capital40.0040.0040.00
Retained earnings-1 033.38-1 989.58
Profit of the financial year-1 033.38- 956.19-1 699.86
Shareholders equity total- 993.38-1 949.58-3 649.44
Non-current owed to group member8 000.008 000.00
Non-current liabilities total8 000.008 000.00
Current loans from credit institutions0.9722.06
Current trade creditors14.35218.76113.84
Current owed to group member3 283.72717.044 460.77
Other non-interest bearing current liabilities105.901 452.502 506.42
Accruals and deferred income20.00184.5380.80
Current liabilities total3 423.962 573.817 183.89
Balance sheet total (liabilities)2 430.588 624.2311 534.45
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.